Detalhe da pesquisa
1.
Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1.
Oncologist
; 28(1): e77-e81, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342342
2.
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 180(3): 647-655, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060783
3.
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
Clin Adv Hematol Oncol
; 9(4): 280-6, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21558987
4.
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).
Nat Commun
; 11(1): 5824, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203854
5.
Obesity and nonadherence correlate with elevated serum estradiol levels in postmenopausal women receiving adjuvant aromatase inhibitor therapy.
Breast J
; 20(5): 553-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25088121